Overview of Dr. Maron
Dr. Steven Maron is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 6 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 89 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He has more than 50 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2017
Yale-New Haven Medical CenterResidency, Internal Medicine, 2011 - 2014
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2011
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2018 - 2026
NJ State Medical License 2019 - 2025
IL State Medical License 2014 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- A Study of Amivantamab in People With Esophagogastric Cancer Start of enrollment: 2021 Dec 02
Roles: Principal Investigator, Contact
- A Study of Tooth Erosion in People With Esophagogastric Cancer Start of enrollment: 2022 Nov 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastases.Chengcheng Gui, Henry S Walch, Kirin D Mueller, Lillian A Boe, A Turan Ilica
Journal of Neurosurgery. 2024-08-30 - Circulating tumor DNA molecular analyses and real-world evidence outcomes of FGFR2 amplified gastroesophageal cancers.Bushra Shariff, Reagan M Barnett, Farshid Dayyani, Steven B Maron, Rory Mcgriskin
The Oncologist. 2024-08-05 - The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors.Filippo Ghelardi, Giovanni Fucà, Chiara Cavalli, Kohei Shitara, Romain Cohen
Digestive and Liver Disease. 2024-05-20
Press Mentions
Tumor HeterogeneityApril 1st, 2020
MSK Research Highlights July 17, 2023July 19th, 2023- MSK Research Highlights, July 17, 2023February 13th, 2024
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
